Chronic Lymphocytic Leukemia: Clinical Trials

37 trials for Chronic Lymphocytic Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed, 8 unknown, 6 terminated, 4 active not recruiting. 37 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable37Completed 13, Unknown 8, Terminated 6, Active not recruiting 4, Recruiting 4, Not yet recruiting 2

Follow Chronic Lymphocytic Leukemia: new trials by email Literature Review of Chronic Lymphocytic Leukemia trials Research Report on Chronic Lymphocytic Leukemia

Trials (filtered) newest first · largest first

All 37 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
This Clinical Trial is a Single-arm, Non-randomized Pilot Trial to Determine the Safety of Administering Autologous Anti-C19 Cells (ARI-0001) and the Feasibility of Local CAR-T Cell Production in Patients Over 18 Years of Age With Relapsed/Refractory (R/R) CD19+ Hematologic Malignancies, Including R
ARI-0001 T cells with anti-CD19 chimeric antigen receptor (CAR-T) - Adult B-cell Acute Lymphoblastic Leukemia, Follicular Lymphoma (FL)
Not applicableNot yet recruitingGUSTAVO SALGUERO122026-09-012026-02-17
Evaluation of Skin Tests in Biotherapy Allergies
Drug skin tests (investigating hypersensitivity to a biotherapy) - Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck, Melanoma Neoplasms
Not applicableRecruitingUniversity Hospital, Angers702026-06-172026-06-18
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
Exercise, Diet - Indolent Lymphomas, Lymphoma
Not applicableRecruitingUNC Lineberger Comprehensive Cancer Center402025-06-032026-07-01
Biological and Clinical Efficacy of Shingrix in Patients With CLL
serologic response evaluation - Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Not applicableNot yet recruitingGruppo Italiano Malattie EMatologiche dell'Adulto3122024-08-012024-05-09
A Single Arm Study of Acalabrutinib Conbimed With Obinutuzumab in Chinese Patients With Previously Untreated CLL
Acalabrutinib, Obinutuzumab - Chronic Lymphocytic Leukemia
Not applicableUnknownThe First Affiliated Hospital with Nanjing Medical University892024-04-162024-05-09
Exercise As Intervention in Chronic Lymphocytic Leukemia
Exercise Training as Intervention - Chronic Lymphocytic Leukemia
Not applicableActive not recruitingUniversidade do Porto112023-09-012025-03-19
HEALTH4CLL2: A Randomized Waitlist Control Trial of Behavioral Interventions in Patients With Chronic Lymphocytic Leukemia
Questionnaires, Fit Bit - Chronic Lymphocytic Leukemia
Not applicableActive not recruitingM.D. Anderson Cancer Center302023-05-172026-09-18
Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors
Medtronic LINQ-2 Insertable Cardiac Monitor (ILR) - Atrial Fibrillation, Supraventricular Arrhythmia
Not applicableRecruitingNorthwell Health502023-01-012025-09-18
Investigating the Role of Energy Balance Modification on Health Responses in Chronic Lymphocytic Leukaemia
HIT, EXE+ Nutritional Guidance - Chronic Lymphocytic Leukemia, Frailty
Not applicableUnknownUniversity of Surrey1322022-10-142024-04-24
MargheRITA (Remote Intelligence for Therapeutic Adherence)
RITA (App) - Multiple Myeloma, Solitary Plasmacytoma
Not applicableCompletedAdvice Pharma Group srl1242022-06-042024-11-06
Description of the Immune Deficiency in Patients With Untreated Chronic Lymphocytic Leukemia and Search for Predictive Factors of Infectious Risk
Blood sampling & Chest CT without injection - Chronic Lymphocytic Leukemia
Not applicableRecruitingCHU de Reims752022-05-102024-06-26
Impact of Treatment With Targeted Therapies on the Generation of CAR T Cells in CLL Patients
Peripheral blood samples withdrawal - CLL, Chronic Lymphocytic Leukemia
Not applicableUnknownGruppo Italiano Malattie EMatologiche dell'Adulto232021-10-012022-01-04
Mobilising Tumour and Immune Cells Via Exercise in Chronic Lymphocytic Leukaemia
Exercise trial - Chronic Lymphocytic Leukemia, Minimal Residual Disease
Not applicableCompletedUniversity of Bath262021-10-012023-09-08
Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study
Health Promotion and Education, Medical Device Usage and Evaluation, Quality-of-Life Assessment - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Not applicableCompletedOhio State University Comprehensive Cancer Center302021-06-112026-04-06
Pharmacists Coordinated Care Oncology Model (PCOM) for Patients Taking Oral Anti-cancer Medications
Patient Reported Outcome Measure (PROM), Comprehensive Medication Review (CMR), Communications between oncology and primary care pharmacists - Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia
Not applicableTerminatedUniversity of Michigan Rogel Cancer Center62021-03-262022-11-22
Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence
Patient-reported outcome measure, Comprehensive Medication Review, Pharmacist communication - Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia
Not applicableUnknownUniversity of Tennessee302021-02-082023-12-04
Safety, Efficacy of BNT162b2 mRNA Vaccine in CLL
COVID-19 serology - Chronic Lymphocytic Leukemia
Not applicableUnknownBnai Zion Medical Center10002021-02-012021-09-17
MyPal ePRO-based Early Palliative Care System in Adult Patients With Hematologic Malignancies
Administration of the MyPal ePRO system - Chronic Lymphocytic Leukemia, Myelodysplastic Syndromes
Not applicableUnknownCentre for Research and Technology Hellas3002021-01-012021-08-04
Multiple Myeloma/Chronic Lymphocytic Leukemia Coach RCT
Myeloma Coach or CLL Coach Mobile App, Springboard Beyond Cancer informational website - Multiple Myeloma, Chronic Lymphocytic Leukemia
Not applicableCompletedDuke University772020-12-172023-07-03
Effect of Digital Health Coaching Program on Self-efficacy and Patient Reported Outcomes of Patients With Newly Diagnosed Acute Myeloid Leukemia or Chronic Lymphocytic Leukemia
Educational Intervention, Questionnaire Administration, Supportive Care - Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia
Not applicableCompletedM.D. Anderson Cancer Center1572020-03-172023-09-18

Showing 20 of 37. Sign in to see all of them.

Narrower conditions

Leukemia, Lymphocytic, Chronic, B-Cell (37)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (10)  ·  Multiple Myeloma (10)  ·  Leukemia, Myeloid, Acute (7)  ·  Lymphoma, Non-Hodgkin (7)  ·  Hodgkin Disease (6)  ·  Lymphoma, Mantle-Cell (5)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (5)  ·  Lymphoma, Follicular (4)  ·  Myelodysplastic Syndromes (4)  ·  Anemia, Aplastic (3)  ·  Anemia, Refractory, with Excess of Blasts (3)  ·  Leukemia (3)  ·  Lymphoma, Large B-Cell, Diffuse (3)  ·  Motor Activity (3)

Broader conditions

Chronic Disease (37)  ·  Disease Attributes (37)  ·  Hematologic Diseases (37)  ·  Hemic and Lymphatic Diseases (37)  ·  Immune System Diseases (37)  ·  Immunoproliferative Disorders (37)  ·  Leukemia, B-Cell (37)  ·  Leukemia, Lymphoid (37)  ·  Lymphatic Diseases (37)  ·  Lymphoproliferative Disorders (37)  ·  Neoplasms by Histologic Type (37)  ·  Pathologic Processes (37)  ·  Pathological Conditions, Signs and Symptoms (37)  ·  Neoplasms (36)  ·  Leukemia (34)

Interventions

Exercise (3)  ·  Cholecalciferol (2)  ·  Cyclophosphamide (2)  ·  Cyclosporine (2)  ·  Early Intervention, Educational (2)  ·  Educational Status (2)  ·  Methods (2)  ·  Patient Reported Outcome Measures (2)  ·  fludarabine (2)  ·  Alemtuzumab (1)  ·  Basiliximab (1)  ·  Blood Specimen Collection (1)  ·  COVID-19 Serological Testing (1)  ·  Diet (1)  ·  Diet Therapy (1)

Sponsors

M.D. Anderson Cancer Center (4)  ·  Duke University (3)  ·  Gruppo Italiano Malattie EMatologiche dell'Adulto (2)  ·  Northwell Health (2)  ·  Scripps Health (2)  ·  Advice Pharma Group srl (1)  ·  All India Institute of Medical Sciences (1)  ·  Barbara Ann Karmanos Cancer Institute (1)  ·  Bnai Zion Medical Center (1)  ·  CHU de Reims (1)  ·  Centre for Research and Technology Hellas (1)  ·  GUSTAVO SALGUERO (1)  ·  Indiana University (1)  ·  Institut Paoli-Calmettes (1)  ·  Masonic Cancer Center, University of Minnesota (1)

Countries

United States (21)  ·  France (4)  ·  Italy (4)  ·  United Kingdom (2)  ·  China (1)  ·  India (1)  ·  Israel (1)  ·  Portugal (1)

Top investigators

David Bartlett, PhD (2)  ·  Alessandra Ferrajoli, MD (1)  ·  Alessandro Flavio Ferri (1)  ·  Andrea Sitlinger, MD (1)  ·  Christopher Jensen, MD MSCR (1)  ·  Claudio Brunstein, MD (1)  ·  Courtney DiNardo (1)  ·  Gustavo Salguero, MD PhD MBA (1)  ·  Haisam Ismail, MD (1)  ·  Jeffrey W. Andrey, M.D. (1)  ·  Jeffrey W. Andrey, MD (1)  ·  Jianyong Li, PhD, MD (1)  ·  John P Campbell, PhD (1)  ·  Julie M Vose, MD, MBA (1)  ·  Kanti R. Rai, MD (1)

Results publications

PMID 1009120, PMID 1068773, PMID 10771143, PMID 1131339, PMID 11333192, PMID 11703167, PMID 1250252, PMID 14965792, PMID 15092991, PMID 15689032, PMID 1719661, PMID 19897186, PMID 21540277, PMID 21827276, PMID 22235210, PMID 22293416, PMID 22945569, PMID 24368178, PMID 25009099, PMID 25445091, PMID 26185180, PMID 26264017, PMID 26508811, PMID 2738890, PMID 27486361, PMID 30778715, PMID 3149183, PMID 34728446, PMID 34848750, PMID 34861036, PMID 36096873, PMID 36946440, PMID 37410541, PMID 37738323, PMID 40278640, PMID 40854168, PMID 41894682, PMID 4513535, PMID 4609793, PMID 6363310, PMID 6824602, PMID 7023931, PMID 9630463

NIH funding

P30CA036727 (1), P50CA097274 (1)